Lipoprotein(a): cardiovascular risk and emerging therapies.
Masashi FujinoStephen J NichollsPublished in: Expert review of cardiovascular therapy (2023)
New Lp(a) lowering therapies have the potential to contribute to the personalized prevention of ASCVD.
Keyphrases